The estimated net worth of Michael Catlin is at least $27.7K dollars as of March 20, 2024. Michael Catlin is the Director of Kiromic Biopharma, Inc. and owns shares of Kiromic Biopharma, Inc. (KRBPQ) stock worth about $27.7K.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.